Found: 14
Select item for more details and to access through your institution.
DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.
- Published in:
- Infection, 2023, v. 51, n. 3, p. 641, doi. 10.1007/s15010-022-01904-w
- By:
- Publication type:
- Article
Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride.
- Published in:
- Nephrology, 2011, v. 16, n. 8, p. 743, doi. 10.1111/j.1440-1797.2011.01509.x
- By:
- Publication type:
- Article
Comment on: Real-life effectiveness of canakinumab in cryoprin-associated periodic syndrome.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.
- Published in:
- Rheumatology, 2017, v. 56, n. 9, p. 1484, doi. 10.1093/rheumatology/kex185
- By:
- Publication type:
- Article
Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.
- Published in:
- Pediatric Rheumatology, 2015, v. 13, p. 1, doi. 10.1186/s12969-015-0047-3
- By:
- Publication type:
- Article
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 8, p. 1679, doi. 10.1002/art.40146
- By:
- Publication type:
- Article
ELEVATE: an innovative study design to assess the efficacy, safety, and evolution of cardiovascular parameters in de novo kidney transplant recipients after early conversion from a calcineurin inhibitor to everolimus.
- Published in:
- Open Access Journal of Clinical Trials, 2014, v. 6, p. 17, doi. 10.2147/OAJCT.S59549
- By:
- Publication type:
- Article
Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function.
- Published in:
- Clinical & Experimental Immunology, 2023, v. 213, n. 3, p. 265, doi. 10.1093/cei/uxad065
- By:
- Publication type:
- Article
First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 5, p. 1, doi. 10.1111/cts.13789
- By:
- Publication type:
- Article
Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
- Published in:
- Clinical Transplantation, 2006, v. 20, n. 3, p. 272, doi. 10.1111/j.1399-0012.2005.00485.x
- By:
- Publication type:
- Article
The role of everolimus in liver transplantation.
- Published in:
- Clinical & Experimental Gastroenterology, 2014, v. 7, p. 329, doi. 10.2147/CEG.S41780
- By:
- Publication type:
- Article
Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 1, p. 135, doi. 10.1007/s10157-013-0815-7
- By:
- Publication type:
- Article
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation.
- Published in:
- Transplant International, 2012, v. 25, n. 5, p. 592, doi. 10.1111/j.1432-2277.2012.01465.x
- By:
- Publication type:
- Article
Graft versus host disease after liver transplantation – a single center experience and review of literature.
- Published in:
- Transplant International, 2008, v. 21, n. 5, p. 441, doi. 10.1111/j.1432-2277.2007.00625.x
- By:
- Publication type:
- Article